Skip to main content
OpenTrials

Clinical trial condition

Jacobs syndrome

Explore clinical trials studying Jacobs syndrome. Study availability and eligibility vary by location and protocol.

21 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Jacobs syndrome trial results

Completed

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy

NCT00102726

Conditions
Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +4 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Greenbrae, California, United States
  • GSK Investigational Site Long Beach, California, United States
View all 95 locations
View Trial Details
Completed

Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390

NCT00996216

Conditions
Blood Platelet Disorders, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site New Haven, Connecticut, United States
  • GSK Investigational Site Honolulu, Hawaii, United States
  • GSK Investigational Site Manhasset, New York, United States
View all 28 locations
View Trial Details
Completed

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease

NCT00529568

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Anaheim, California, United States
  • GSK Investigational Site Arcadia, California, United States
View all 227 locations
View Trial Details
Completed

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

NCT00516321

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site La Jolla, California, United States
View all 191 locations
View Trial Details
Completed

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)

NCT00102739

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • GSK Investigational Site Bad Nauheim, Hesse, Germany
  • GSK Investigational Site Athens, Greece
  • GSK Investigational Site Athens, Greece
  • GSK Investigational Site Thessaloniki, Greece
View all 30 locations
View Trial Details
Completed

SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C

NCT00110799

Conditions
Blood Platelet Disorders, Blood-Borne Infections, Chronic Disease, +20 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site St Louis, Missouri, United States
View all 30 locations
View Trial Details

Related conditions